D, B., & M, N. (2021). Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer. Lung Cancer: Targets and Therapy, ume 12, 133-138.
Chicago Style (17th ed.) CitationD, Brazel, and Nagasaka M. "Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer." Lung Cancer: Targets and Therapy ume 12 (2021): 133-138.
MLA (9th ed.) CitationD, Brazel, and Nagasaka M. "Spotlight on Amivantamab (JNJ-61186372) for EGFR Exon 20 Insertions Positive Non-Small Cell Lung Cancer." Lung Cancer: Targets and Therapy, vol. ume 12, 2021, pp. 133-138.
Warning: These citations may not always be 100% accurate.
